<DOC>
	<DOCNO>NCT00365443</DOCNO>
	<brief_summary>This study evaluate investigational vaccine follow objective : ( 1 ) To demonstrate prevention cervical , vulvar , vaginal cancer related precancers , external genital lesion , persistent infection cause HPV type study vaccine , ( 2 ) To demonstrate vaccine well-tolerated woman , ( 3 ) To evaluate vaccine immune response woman . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Broad Spectrum HPV Vaccine Tolerability , Immunogenicity , Efficacy Study ( V502-003 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Female , age 16 26 History abnormal PAP test abnormal cervical biopsy result History external genital/vaginal wart History positive HPV test Currently user illegal drug alcohol abuser Are pregnant Currently enrol another clinical trial Currently history certain medical condition currently take take certain medication ( detail discuss time consent ) .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>anogenital wart</keyword>
	<keyword>premalignancy</keyword>
	<keyword>HPV</keyword>
	<keyword>Human papillomavirus</keyword>
</DOC>